Next |
home / stock / aktx / aktx message board
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Rogerthat1 | investorshub | 07/03/2023 10:19:08 PM |
$AKTX Good read | mick | investorshub | 07/03/2023 6:42:07 PM |
$AKTX The gaining | mick | investorshub | 07/03/2023 5:19:37 PM |
The now up | mick | investorshub | 07/02/2023 1:19:36 PM |
The gaining up | mick | investorshub | 07/01/2023 11:35:05 PM |
Do we have a winner?Turn around time? | mick | investorshub | 06/27/2023 4:48:27 PM |
MomentumIts trading last trade up | MotionOffense78 | investorshub | 06/26/2023 11:01:59 PM |
Thoughts on where this is headed? | mick | investorshub | 06/26/2023 11:52:44 AM |
$AKTX Time for this to show some returns | Rogerthat1 | investorshub | 06/22/2023 2:59:27 AM |
$AKTX got some short data | Rogerthat1 | investorshub | 06/16/2023 7:34:15 AM |
The gaining | mick | investorshub | 06/15/2023 1:52:01 AM |
Found an interesting article | mick | investorshub | 06/14/2023 10:26:08 AM |
$AKTX MomentumIts gaining last up | mick | investorshub | 06/14/2023 5:23:14 AM |
$AKTX MomentumIts now last trade up | candeloro | investorshub | 06/13/2023 12:08:29 PM |
$AKTX The trading up | Rogerthat1 | investorshub | 06/13/2023 3:27:44 AM |
Time for this to show some returns | mick | investorshub | 06/12/2023 3:31:10 AM |
what do you make of this data? | mick | investorshub | 06/10/2023 9:47:36 PM |
$AKTX Time for this to show some returns | mick | investorshub | 06/10/2023 3:23:23 AM |
are we finally gonna see some action | mick | investorshub | 06/09/2023 2:05:11 PM |
MomentumIts gaining up | MotionOffense78 | investorshub | 06/09/2023 12:05:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Akari Therapeutics Plc Company Name:
AKTX Stock Symbol:
NASDAQ Market:
BOSTON and LONDON, April 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will present new pre-clinical data on investigational long-acting PAS-nomacopan...
BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights. ...
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...